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Our investigation was centered on a possible relationship between the toxicity of
cadmium andchanges inits chemical forms intissues. Twomodels have been studied: one
is the renal damage induced by a singleinjection ofcadmium-containing metallothionein
and the other is the renal damage induced by repeated injections ofcadmium salt.
Parenteral loading of cadmium-containing metallothionein caused acute and transi-
torynecrotic damage ofrenaltubularliningcells. This was explainedby the selective and
rapid uptake ofmetallothionein at the proximal tubules and degradation ofthe protein,
resulting in liberation ofcadmium ions.
Cadmium ions were injected repeatedly into rats, and the changes in the chemical
forms of cadmium, zinc and copper in the liver and kidneys were correlated with the
histological observations. The transitory necrotic damage ofthe proximal tubules caused
duringthe repeatedinjections ofcadmium was accompanied with a rapid decrease ofthe
copper content in the kidney metallothionein. Further loading ofcadmium ions induced.
increases in the amounts of cadmium not bound to metallothionein and its oxidation
products as well as an increase ofthe Cd/Zn ratio in metallothionein. With these changes
in the chemical forms ofcadmium, persistent damage ofthe kidneys occurred.
The transitory renal damage caused both by a single injection ofcadmium-containing
metallothionein and by repeated injections ofcadmium salt can be explained by a limit of
the native biosynthetic capacity of metallothionein in the kidney, while the persistent
damage appears to be due to a limit ofthe induced capacity.
Cadmium in living tissues is mostly bound to
an inducible low molecular weight metal-binding
protein, metallothionein, which is usually
present as an intracellular soluble protein. Metal-
lothionein is assumed to have several biological
functions (1), the most important one being the
protection of the organism from toxic effects of
harmful heavy metals, especially from cadmium
(2-5). In fact, cadmium bound to metallothionein
is not toxic in vitro, and metallothionein does not
show toxic effects as long as it remains an intra-
cellular protein.
Although the biological half-life ofcadmium is
extremely long and cadmium is present as bound
to metallothionein, the biological half-life of the
apoprotein, thionein, is as short as those ofusual
proteins (6-9). This fact suggests that the toxicity
ofcadmium maybe due to metal ions notbound to
metallothionein and that the toxicity is possibly
related to the capacity of metallothionein biosy-
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nthesis in tissues. Therefore, our approach was
focused on a limit detection of the biosynthetic
capacity ofmetallothionein and on the examina-
tion ofchanges in the chemical forms ofcadmium
after loading with cadmium in various ways.
We selected two models to clarify a possible
relationship between the toxicity ofcadmium and
changes in its chemical forms: induction ofrenal
damages by (a) parenteral loadings with cad-
mium-containing metallothioneins and (b) re-
peated injections ofcadmium salts. The results of
our investigations on the two models will be re-
viewed in this communication with some sche-
matic presentations.
Renal Damage Induced by Single
Injections of Cadmium-Containing
Metallothioneins
One of the proposed biological roles of metal-
lothionein is its function as a carrier protein for
metals such as cadmium, zinc and copper, espe-cially from the liver to kidneys. Tanaka et al. (10)
and Cherian and Shaikh (11) examined this bio-
logical role by administering parenterally an iso-
lated and labeled metallothionein. In contrast to
ionic cadmium, the metal bound to metallothio-
nein was less effectively trapped by the liver and
was mostly taken up by the kidney. The selective
transfer of cadmium bound to metallothionein
has been confirmed in many laboratories (12-16).
Nordberg et al. (17) and Cherian et al. (18)
demonstrated that parenteral administration of
metallothionein causes severe necrotic damage to
the kidney. This observation contradicts one of
the assumed biological roles of metallothionein,
that is, the protection of the living body from
harmful effects ofcadmium by sequestering it as
a stable complex. Two possibilities have been
pointed out to explain the potent nephrotoxic
action of parenterally administered metallothio-
nein (13,14,16-19): one is the toxicity of metal-
lothionein itself and the other is the toxicity of
ionic cadmium liberated from metallothionein.
Our approach was to correlate the changes in
the chemical forms ofcadmium with the histolog-
ical change ofthe renal tubular lining cells after
administration of metallothioneins having vari-
ous metal compositions. The metallothioneins
used in our experiment were as follows (14):
Cd,Zn-thionein (native rat liver metallothionein)
(20), Cd,Cu,Zn-thionein (native rat kidney metal-
lothionein) (21) and Cd-thionein (artifical rat
liver metallothionein) (22-24). The results ofour
experiments can be summarized as follows.
Time-dependent changes in the chemical forms
of cadmium in the kidney supernatant were
traced by gel filtration chromatography after a
single injection of cadmium-containing metal-
lothioneins. Cadmium was selectively taken up
by the kidney shortly after the administration,
and the distribution profiles of cadmium in the
supernatant fraction changed dramatically after
the uptake. Cadmium was present in the metal-
lothionein fraction at first, and then the metal
changed the distribution to the high molecular
weight protein fraction at the expense of the
metal in the metallothionein fraction. Cadmium
in the high molecular weight protein fraction
started to decrease about 6 hr after injection, and
the metal in the metallothionein fraction in-
creased. Finally, mostofcadmiumwas confinedto
the metallothionein fraction again. This change
in the distribution of cadmium can be explained
by the degradation and resynthesis of metal-
lothionein in the kidney, because the cadmium in
thehigh molecular weightprotein fraction can be
explained only by nonselective binding of the
cadmium ions liberated from the degraded metal-
lothionein (25).
The degradation and resynthesis of metal-
lothionein in the kidney was further examinedby
tracing the changes in the distribution profiles of
zinc and copper after the injection ofmetallothio-
nein. The distribution profiles of the two metals
showed an identical or at least a similar change,
even when metallothioneins of different metal
compositions were injected. Although zinc was
not found in the metallothionein fraction until
most ofthe cadmium in the supernatant fraction
was redistributed to the metallothionein fraction
(the affinityofzingto metallothionein is lessthan
thatofcadmium), zincwas alwayspresent as aco-
existing metal in the metallothionein fraction 1
dayafterinjection. Furthermore, althoughcopper
is a major co-existing metal in the kidney metal-
lothionein when cadmium ions are administered
(26,27), copper was present only as a minor co-
existing metal in the resynthesized metallothio-
nein even when Cd,Cu,Zu-thionein was injected
(21).
Parenteral administration of metallothioneins
with differing cadmium/zinc ratios revealed that
the extent ofnecrotic damage ofthe tubular lin-
ings depends on the amount of cadmium in the
injected metallothionein but not on that ofmetal-
lothionein (protein) (24).
The renal damage was found to be a transitory
one, and the time course of the histological
change was well correlated to the changes in the
distribution profiles of cadmium in the kidney
(20,21,23,24). As a result, we suggested that the
toxicityofparenterally administeredmetallothio-
nein is due to the cadmium ion liberated from the
degraded metallothionein, the cadmium ions be-
ing found in the high molecular weight protein
fraction. Furthermore, the metal composition in
the resynthesized metallothionein was found to
be different from that induced by loading ofcad-
miumions; theformercontainszinc as amajorco-
existing metal (20-24), whereas in the latter cop-
per is predominant (26,27).
Selective Transfer and Uptake of
Cadmium Bound to
Metallothionein by the Kidney
The selective transfer of cadmium to metal-
lothionein to the kidneys is a clue to clarify the
mechanisms ofthe renal damage caused not only
by the injection of cadmium-containing metal-
lothionein but also by exposure to cadmium salt
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i) Cd-high molecular weight complexes (Cd-plasma proteins)
ii) Cd-low molecular weight complexes (MT, low molecular weight complexans)
with higher stability constants than those to plasma proteins
iii) Cd-low molecular weight complexes that can be reabsorbed at the tubules
such as MT
iv) Cd-low molecular weight complexes that are not reabsorbed at the tubules
FIGURE 1. Schematic presentation ofcadmium distribution in
tissues according to the molecular sizes and stability con-
stants ofcadmium complexes in plasma.
in chronic cadmium poisoning. For the selective
transfer of cadmium to the kidney, cadmium is
required to be bound in plasma to low molecular
weight complexes that can be freely filtered
through the glomeruli. At the same time the
stability constants of the cadmium complexes
need to be higher than those ofcadmium-plasma
high molecular weight proteins.
Metallothionein meets this prerequisite and is
selectivelytransferred tothekidney. Ontheother
hand, cadmium ions in plasma are mostly bound
to the high molecular weight proteins and are
effectively trapped by the liver (25). When low
molecular weight chelating agents work as an
effective vehicle for cadmium, the distribution of
the metal between the liver andkidney is altered,
and the metal is more effectively transferred to
the kidney than to the liver. The distribution of
cadmium between thehigh molecularweightpro-
teins and low molecular weight chelating agents
in plasma is certainly also affected by the molar
ratio of cadmium to the chelating agents. The
predominant transfer of cadmium to the kidney
in the case ofhigher cysteine ratios (28) supports
this assumption.
Reabsorption mechanisms of cadmium com-
plexes at the proximal tubules will have to be
investigated further; however, that of metal-
lothionein has been studied in detail (12).
The tissue distribution ofcadmium is schemati-
cally shown in Figure 1, based on the discussion
above and our data that support this discussion
(29,30).
Renal Damage Induced by
Repeated Injections of Cadmium
Salt
Repeated injections ofcadmium salt resulted in
the accumulation of cadmium in tissues, espe-
cially in the liver and kidney. This investigation
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FIGURE 2. Changes in the concentrations and content of
cadmium in (A) the liver and (B) kidneys ofrats inducedby
injections of cadmium salt (33). Cadmium chloride was
injected subcutaneously into 30 female rats ofthe Wistar
strain (8 weeks old at the beginning ofthe injection) at the
doseof3.0 mgCd/kgbodyweight, fourinjections aweek up
to 6 weeks. The rats (five heads/group) were killed 3 days
after the last injection in each group. Portions ofthe liver
andkidneysofeach rat werehomogenized in nine volumes
ofan extraction buffer (0.1 M fis/HCl, pH 7.4, containing
0.25 M glucose; dissolved oxygen gas was removed before
usebybubblingnitrogen gas) in anatmosphere ofnitrogen
gas using a Polytron homogenizer. The homogenates were
centrifuged at 170,000g for 60 min; 2 mL portions of the
supernatants were heated at 70°C for 10 min and then
centrifuged at 2300g for 10 min after cooling in an ice-
water bath. Concentrations of cadmium in the homoge-
nates (---), supernatants (), and heat-treated superna-
tants (-L-) multipliedby 10 are expressed as means ± SD
of five samples and plotted versus duration of cadmium
injections. The concentrations of cadmium were deter-
mined simultaneously with other metals by inductively
coupled plasma-atomic emission spectrophotometry (ICP-
AES). Contents ofcadmium ( O*) in the liver and kidneys
were also expressed as means ± SD offive samples.
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FIGURE 3. Distribution profiles of(A) cadmium and (B) zinc in the liver and (C) cadmium, (D) zinc and (E) copper in the kidney
supernatants ofrats injected repeatedly with cadmium salt (33). The distribution profiles ofthe three metals in the liver and
kidney supernatants were determined by applying a 0.1 mL portion ofthe pooled supernatants in each group to an SW column
(TSK gel G3000SW, 7.5 x 600 mm with a precolumn of7.5 x 75 mm; Toyo Soda Co., Tokyo). The column attached to a high
performance liquid chromatograph (HPLC, HLC 803A, Toyo Soda Co.) was eluted with 50 mM Tris/HCl buffer (pH 8.0,
containing 0.1% NaN3, dissolved gases were removed byheating at 80°C under reduced pressure) at aflow rate of1.0 mL/min.
The concentrations ofthe metals were determined by connecting the outlet ofthe column to the nebulizer tube of an atomic
absorption spectrophotometer (AAS, Hitachi 170-50A, Hitachi Ltd.,Tokyo) (HPLC-AASmethod) (34). I(21.2 min) and II (20.2
min) indicate metallothionein-I and -II, respectively. Peaks at retention times of 11.2 (void volume of the column), 18.3
(metallothionein dimers) (35), and22.8 and24.3min(cadmium-bindingproteinsrelatedtometallothionein) (32)wereidentified
as alreadyreported. The vertical bar indicates the detectorlevel ofthe metalbythe corresponding standard metal solution. As
thecolumnwaswashedwellwithmercaptoethanol toremovemetalsboundnonselectively tothecolumn,cadmiumboundtothe
high molecular weight protein fraction was adsorbed to the column and was not observed in the present experiment.
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FIGURE 4. Changes in the concentration and content ofcopper
in the kidneys induced by injections ofcadmium salt (33).
The concentration and content ofcopper in the kidneys of
the rats in the cadmium- and saline-injected groups were
determined as indicated in the legend to Fig. 2. Control
rats (30 heads in total) were injected with physiological
saline at a volume of0.1 mL/rat and the concentrations of
themetals were determined exactly atthe same manner as
mentioned for the cadmium group. The data are expressed
as means ± SD offive samples.
was selected as the second model to examine the
relation between the toxicity ofcadmium and the
changes in its chemical forms. Although the ex-
tent of accumulation depends on the dose and
method ofadministration, we administered a rel-
atively highdose ofcadmium salt into female rats
by subcutaneous injection and studied the possi-
ble relation between the toxicity ofcadmium and
the changes in the chemical forms of cadmium
(14,31-33).
During the repeated injections of cadmium
salts, we have observed the transitory necrotic
damage of renal tubular linings (31,33) that is
similar to the renal lesion observed after the
single injection of cadmium-containing metal-
lothionein. This necrotic damage was transitory,
and the tubular linings were restored despite
further continuous injections of cadmium salt.
Persistent renal damage was observed later after
the transitory necrotic damage. The transitory
and persistent renal damage will be discussed
later in this paper in consideration of the view-
points onthebiosynthetic capacityofmetallothio-
nein.
As shown in Figure 2, the concentration and
content ofcadmium inthe liverandkidney ofrats
changed with repeated injections ofcadmium salt
(33). Cadmium in the two tissues was further
separated into metal extractable to the soluble
fraction and also to the heat-stable soluble frac-
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FIGURE 5. Changes in the concentrations and contents ofzinc
in (A) the liver and (B) kidneys of rats induced by injec-
tions of cadmium salt (33). The concentrations of zinc in
the livers and kidneys of the rats in the cadmium- and
saline-injected groups were determined as indicated in the
legend to Figs. 2 and 4 and were plotted versus duration of
the injection. Thedata are expressed as means ± SD offive
samples and absence of a bar indicates that the range is
less than the size ofthe symbol.
tion. Cadmium in the latter two fractions was
bound mostly to metallothionein and its related
cadmium-binding proteins (Fig. 3) (33). The dif-
ference in cadmium concentration between the
whole tissue and the heat-stable soluble fraction
does not exactly show the concentration of cad-
mium not bound to metallothionein but is closely
related to it.
The renal tubular linings were severely dam-
aged after injections for two weeks and then were
restored despite further continuous injections.
However, no appreciable signs that may indicate
transitory damage were observed from the
changes in the cadmium concentrations and con-
tent in the kidney. On the other hand, the copper
concentration in the kidney showed a dramatic
change at this stage as shown in Figure 4 (31,33).
The copper concentration that continued to in-
crease with accumulation ofcadmium in the kid-
ney (26,27) suddenly dropped to the control level
afterthe damage. The copper concentration inthe
kidney decreased to lower levels than those ofthe
respective controls with further injections ofcad-
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FIGURE 6. Changes in the amounts of urinary (A) cadmium,
(B) zinc and (C) copper induced by repeated injections of
cadmium salt (33). Urine of the rats repeatedly injected
either with cadmium or saline as indicated in the legends
to Figs. 2 and 4 was collected for 24 hr, 3 days afterthe last
injection for the respective injection periods using a meta-
bolic cage. The amounts of the three metals excreted into
urine are expressed as jg/day/rat and means + SD offive
samples. The concentrations were determined by atomic
absorption spectrophotometry after wet-ashing.
mium. However, this transitory damage was not
characterized by another co-existing metal, zinc,
in metallothionein (Fig. 5) (33). On the other
hand, increases in the amounts of the three
metals in the urine were observed after this tran-
sitory damage (Fig. 6).
The transitory renal damage caused by re-
peated injections of cadmium salt can thus be
characterized by the changes in metal concentra-
tion as follows: (1) the damage occurs after accu-
mulation of cadmium to about 100 jg/g kidney.
(2) The concentration of copper in the kidney
decreases dramatically afterthe damage, andthis
change is characterized by a sudden decrease of
copper content in the kidney metallothionein. (3)
Cadmium is bound to copper-rich metallothionein
before the damage, while it is bound to metal-
lothionein containing far smaller amounts of co-
existing metals (copper and zinc), especially cop-
per, after the damage (Fig. 3).
Cadmium in the kidney continued to increase
both in concentration and content with the injec-
tions ofcadmium even after the transitory dam-
age, and the concentration reached almost a pla-
teau after injections for 5 weeks (Fig. 2B).
Although the extent and rate of cadmium accu-
mulation inthe kidneywere farlessthanthose in
the liver (Fig. 2A), cadmium in the kidney seems
to accumulate in a similar manner to that in the
liver; the concentration attained a plateau faster
than the content, and the difference of cadmium
concentrations between the whole tissue and the
heat-treated supernatant fraction was wide dur-
ing the plateau. Histological examination of the
livers and the kidneys under a light microscope
revealednecrosis ofhepatocytes afterinjection for
5 weeks, while necrotic damage was not observed
after the transitory necrosis and the restoration
(33). These observations suggest that persistent
damage can be induced after the concentration of
cadmium attained a maximum and maintained a
plateau.
We observed changes in the distribution pro-
files of cadmium and zinc in the liver superna-
tants with injections ofcadmium salt and charac-
terized the changes as follows: increase in the
relative ratio of cadmium to zinc in metallothio-
nein; increase in the oxidation products ofmetal-
lothionein; and increase in the amount of cad-
mium not bound to metallothionein and the
related cadmium-binding proteins (32). These ob-
servations have also been reported by Sato and
Nagai (36,37).
As the dose ofcadmium injected in this experi-
ment was high, the liver was damaged earlier
than the kidneys. The concentration and content
of cadmium in the liver also attained maxima
faster than those in the kidneys. The changes in
the distribution profiles ofthe metals in the kid-
ney supernatants after the transitory damage
were similar to those in the liver supernatants
(Fig. 3). Therefore, the persistent renal damage
may result after the three changes in the distri-
butions ofcadmium and zinc (copper) in the kid-
ney supernatants are observed.
Capacity of Metallothionein
Synthesis and Its Relation to the
Toxicity of Cadmium
The renal damage induced by the injection of
cadmium-containing metallothionein was sug-
gested to be caused by free cadmium ions liber-
ated from the degraded metallothionein. The
changes in the distribution profiles of cadmium
and zinc after the degradation ofmetallothionein
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(distribution ofcadmium from thehighmolecular
weight protein fraction to the metallothionein
fraction) are similar to those in the liver superna-
tant after the injection ofcadmium salt, and this
suggests that the biosynthesis ofmetallothionein
isinducedbythe cadmium ionsliberatedfromthe
degraded metallothionein. The metallothionein
induced by the injection of cadmium-containing
metallothionein is not rich in copper and is differ-
ent in metal composition from metallothionein
inducedby exposure to cadmium salt. The copper-
rich metallothionein induced by loadings with
cadmium salt has been explained by the seques-
tration of cadmium ions to the kidney metal-
lothionein within the capacity of native Cu,Zn-
thionein biosynthesis (31). The slow transfer of
cadmium to the kidney in the case of loadings
with cadmium salt is probably sufficient to se-
quester the metal within the native capacity. On
the other hand, a rapid transfer and degradation
of the injected metallothionein in the kidney
would supply too much ionic cadmium to be se-
questered by the native capacity resulting in the
induction ofa new biosynthetic system for metal-
lothionein. The metallothionein resynthesized by
the new biosynthetic system is different in metal
composition from that induced within the native
capacity; poor in copper and similar to that ofthe
liver metallothionein (Cd,Zn-thionein) (20-24).
The transitory renal damage induced by the
repeated injections of cadmium salt can also be
explained by the limit ofthe native biosynthetic
capacity of metallothionein in the kidney. The
slow transfer of cadmium to the kidney in the
case of the injection of cadmium salt is probably
sufficient for cadmium to be sequestered to metal-
lothionein within the native biosynthetic capac-
ity, andthis will result in the induction ofcopper-
rich metallothionein. The native biosynthetic
capacity seems to trap cadmium up to a concen-
tration of about 100 ,ug/g kidney (31,33). When
the concentration of cadmium in the kidney be-
comes higher than this limit, cadmium ions not
bound to metallothionein may increase and cause
thetransitory damage oftherenal tubules. Atthe
same time, the cadmium ion stimulates the new
induction ofmetallothionein synthesis to seques-
ter the cadmium ion as metallothionein poor in
copper (31,33).
The transitory damage of the renal tubular
linings accompanied by the change in the copper
content of metallothionein after the single injec-
tion of cadmium-containing metallothionein and
also after the repeated injections ofcadmium salt
canthusbeexplainedbythe limitofnative capac-
ity of metallothionein biosynthesis followed by
the new induction of metallothionein biosynthe-
sis in the kidney.
The persistent renal damage caused by re-
peated injections ofcadmium salt can be observed
after the concentration of cadmium attains a
maximum plateau level. At this level, the rela-
tive ratio ofcadmium to the co-existing metals is
higher than that before the plateau, and the in-
tra- and intermolecular oxidation products are
more frequently observed in the distribution pro-
files of cadmium. Furthermore, the difference in
cadmium concentration between the whole tissue
and heat-stable soluble fraction is wider than
that before the plateau. As the latter observation
is closely related to the increase in cadmium
concentration not bound to metallothionein, the
persistent renal damage is probably caused also
bythemetal notboundtometallothionein. There-
fore, the persistent damage can probably be
caused only in the presence of persistent cad-
mium ion at a certain concentration beyond the
capacity of metallothionein biosynthesis in tis-
sues.
The concentration ofthe free cadmium ion that
may cause the renal damage probably depends on
species, sex, age and other physiological factors.
Although it is relatively easy to estimate the
concentration of free cadmium ion extractable
into the supernatant fraction, itmightbe difficult
to estimate the concentration in other subcellular
fractions. Nomiyama has estimated the concen-
tration to be 35 and 60 ,ug/g in the kidney super-
natant fractions ofmonkey and rabbit (38,39).
Schematic Presentation of the
Metabolic Pathways of Absorbed
Cadmium in Rats
Metabolic pathways for cadmium absorbed in
rats schematically presented in Figure 7 are
based on the assumed controlling factors for the
tissue distribution ofcadmium shown in Figure 1
and also on the metal compositions related to the
capacity ofmetallothionein synthesis. The metal
compositions in plasma and urinary metallothio-
neins were obtained mainly from data reported
previously (14, 20, 33, 40-42).
The chemical forms ofcadmium in plasma are
the main controlling factors that determine the
distribution of cadmium either to the liver or
kidney; cadmium bound to the high molecular
weight plasma constituents is mostly trapped by
the liver, while the metal bound to the lower
molecularweightcomponents is either selectively
transferred to and taken up by the kidney or
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i) In the case of low accumulation
Cd-low molecular weight complexes
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FIGURE 7. Schematic presentation ofthe metabolic pathways ofabsorbed cadmium in rats.
directly excreted into urine. Although it is not
known whetherthe decrease ofcadmium fromthe
liver is due to a passive mechanism (like enzymes
from damaged cells) or due to an active (secre-
tory) mechanism, Cd,Zn-thionein is excreted into
plasma. Zinc andcadmium inthe metallothionein
coming out of the liver are partly replaced by
copper in plasma. Cadmium is considered to be
either selectively transferred to the kidney as
Cd,Cu-thionein or taken up by the liver as cad-
mium-high molecular weight protein complexes
in plasma.
Ifthe amount ofliver metallothionein excreted
into plasma is small and the concentration of
cadmium in the kidney is low, the metallothio-
nein will be efficiently reabsorbed by the renal
tubules. The reabsorbed metallothionein is de-
graded, and the cadmium liberated from the de-
graded metallothionein is sequestered as the cop-
per-rich metallothionein within the native
biosynthetic capacity. On the other hand, when
the amount ofliver metallothionein excreted into
plasma is high and the concentration ofcadmium
in the kidney is high, the metallothionein may
mostly be not reabsorbed by the tubules and ex-
creted directly into urine. Thus, the origin of
urinary metallothionein may depend on the ex-
tent ofcadmium accumulation in the kidney and
also on the renal damage (reabsorption rate).
The high copper content in the urinary metal-
lothionein is partly explainable by the replace-
ment ofzinc and cadmium in metallothionein by
urinary copper according to the higher affinity of
copper to metallothionein (20,26). The urinary
metallothionein contains copper in high content
irrespective of its origin (plasma and/or urinary
copper) and can be easily oxidized both by diva-
lent copper (43) and by dissolved oxygen. There-
fore, the amount of urinary metallothionein has
to be estimated carefully when it is quantified
from the amount of metals in metallothionein.
The radioimmunoassay (44-46) is probably supe-
rior in its sensitivity in comparison with the
conventional methodbasedonmetal analysis pro-
vided that the radioimmunoassay has the same
detectability for metallothionein with different
metal compositions and oxidation states.
The author expresses his thanks to Dr. K. Kubota for his
continuous encouragement.
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